Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Textual)

v3.2.0.727
Subsequent Events (Details Textual) - USD ($)
$ / shares in Units, $ in Millions
 1 Months Ended
Feb. 13, 2015
Aug. 05, 2015
Jul. 31, 2015
Valeant Pharmaceuticals International Inc [Member] | Licensing Agreements [Member]      
Subsequent Event [Line Items]      
Payments to Acquire Intangible Assets     $ 1.0
Proceeds from Sale of Intangible Assets     $ 32.5
IPO [Member]      
Subsequent Event [Line Items]      
Stock Issued During Period, Shares, New Issues 683,250    
Subsequent Event [Member] | Representative The Underwriters [Member]      
Subsequent Event [Line Items]      
Shares Issued, Price Per Share   $ 8.50  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   176,470  
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.01  
Subsequent Event [Member] | IPO [Member]      
Subsequent Event [Line Items]      
Stock Issued During Period, Shares, New Issues   1,176,470  
Shares Issued, Price Per Share   $ 8.50  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   1,176,470  
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 10.62  
Subsequent Event [Member] | Over-Allotment Option [Member]      
Subsequent Event [Line Items]      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   176,470  
Proceeds from Issuance of Common Stock   $ 8.8